5-Amino-1mq Hplc Verification & Technical Analysis

Direct Answer: What Does 5-Amino-1MQ HPLC Verification Entail?

In analytical chemistry and preclinical research, 5-Amino-1MQ HPLC verification refers to the process of separating, identifying, and quantifying 5-amino-1-methylquinolinium (and its salt forms) using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This method measures chromatographic peak area percentages to confirm that the material meets strict laboratory purity benchmarks—typically exceeding 98.0%—while identifying any residual synthesis impurities or degradants.

Because 5-Amino-1MQ target validation in cell cultures and animal models depends on precise molar dosing without confounding chemical contaminants, RP-HPLC is paired with Electrospray Ionization Mass Spectrometry (ESI-MS) and bacterial endotoxin testing. Every batch supplied by PX1 Research undergoes this comprehensive testing matrix, yielding a lot-specific Certificate of Analysis (COA) to guarantee structural integrity and experimental repeatability.

Chemical Structure and Molecular Profile of 5-Amino-1MQ

5-Amino-1-methylquinolinium, commonly designated as 5-Amino-1MQ, is a synthetic quinolinium derivative engineered specifically to act as a membrane-permeable, selective inhibitor of the cytosolic enzyme nicotinamide N-methyltransferase. Its molecular formula is C10H11N2+ (typically supplied as a iodide or chloride salt), with a monoisotopic mass of 159.09 Da for the parent cation.

Analytical validation of high-purity 5-Amino-1MQ requires distinguishing the target active cation from potential precursor molecules, such as 5-aminoquinoline, and non-methylated intermediates. RP-HPLC resolves these structural analogs based on hydrophobic interactions with a stationary C18 phase, ensuring that batch preparations provided for laboratory research use only maintain rigorous purity standards free of unreacted reagents.

Mechanism of Action: NNMT Inhibition and Cellular Energy Dynamics

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). This irreversible reaction functions as a sink for both methyl groups and nicotinamide, directly limiting the availability of NAM required for the NAD+ salvage pathway.

Preclinical studies indicate that elevated NNMT activity is associated with suppressed intracellular NAD+ levels and altered methyl donor availability in metabolic tissues. By selectively inhibiting NNMT enzyme activity, 5-Amino-1MQ halts the conversion of NAM to 1-MNA. In vitro assays demonstrate that this blockade increases intracellular nicotinamide availability, thereby enhancing the replenishment of cellular NAD+ pools through the enzymatic action of nicotinamide phosphoribosyltransferase (NAMPT).

Furthermore, researchers studying NNMT inhibitors focus on how altering the SAM/SAH ratio via NNMT inhibition modulates epigenetic histone methylation, altering transcriptional profiles associated with energy expenditure and substrate utilization.

Preclinical Literature: NAD+ Elevation, Mitochondrial Output, and Fat Metabolism

In vitro data and rodent model studies have established 5-Amino-1MQ as a pivotal tool compound for investigating adipose tissue remodeling and metabolic regulation. In diet-induced obese (DIO) mouse models, administration of 5-Amino-1MQ demonstrated significant reductions in adipocyte soma size and overall body mass without altering food intake, suggesting a direct effect on basal metabolic rate and cellular respiration.

Mechanistically, research indicates that the upregulation of NAD+ resulting from NNMT inhibition activates sirtuin 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP1) signaling axes. Activation of SIRT1 promotes the deacetylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis. As a consequence, rodent models treated with NNMT inhibitors exhibit increased oxygen consumption rates (OCR) and enhanced mitochondrial oxidative phosphorylation capacity in white adipose tissue.

These empirical findings positioned 5-Amino-1MQ as a core focus in NAD+ cellular salvage pathways research, specifically regarding how localized enzyme inhibition can reverse age- or diet-related metabolic decline at the cellular level.

RP-HPLC Analytical Methodology for 5-Amino-1MQ Verification

To ensure high-resolution separation of 5-Amino-1MQ during RP-HPLC evaluation, laboratory technicians utilize optimized gradient elution parameters. A typical analytical protocol employs a reverse-phase C18 column (e.g., 4.6 mm × 150 mm, 3.5 µm particle size) maintained at a constant temperature of 25°C to 30°C.

Mobile phase A generally consists of HPLC-grade water with 0.1% trifluoroacetic acid (TFA) or formic acid as an ion-pairing agent, while Mobile Phase B consists of acetonitrile (ACN) containing 0.1% of the matching acid modifier. A typical gradient run transitions from 5% B to 60% B over 15 to 20 minutes at a flow rate of 1.0 mL/min. Ultraviolet (UV) detection is typically performed at 242 nm or 360 nm, corresponding to the characteristic absorbance maxima of the quinolinium core structure.

Purity is calculated via peak area normalization: the area of the primary 5-Amino-1MQ peak is expressed as a percentage of the total integrated peak area across the spectrum. A sample achieving ≥98.0% peak area purity indicates that trace organic impurities fall below standard analytical threshold limits required for reliable in vitro testing.

Mass Spectrometry, Endotoxin Testing, and Quality Parameters

While RP-HPLC establishes chemical purity via retention time and UV absorbance, Mass Spectrometry (MS) provides unambiguous structural confirmation by measuring the mass-to-charge ratio (m/z) of the molecule. Electrospray Ionization Mass Spectrometry (ESI-MS) operating in positive ion mode should yield a prominent parent ion peak at m/z 159.1 [M]+, confirming the precise molecular weight of the 5-amino-1-methylquinolinium cation.

In addition to organic purity and structural verification, preclinical research compounds intended for cell culture or animal models must be screened for bacterial endotoxins (lipopolysaccharides). High endotoxin concentrations introduce severe confounding variables by inducing inflammatory cytokine responses (e.g., TNF-α, IL-6) in macrophage and adipocyte cultures.

PX1 Research conducts mandatory chromogenic Limulus Amebocyte Lysate (LAL) testing on every lot. By maintaining endotoxin limits below strict research-grade thresholds (<0.05 EU/mg), PX1 ensures that experimental outcomes reflect true NNMT inhibition rather than immune activation caused by bacterial contaminants.

Comparative Analysis: Metabolic & Energy Homeostasis Research Compounds

When designing preclinical metabolic trials, researchers frequently compare 5-Amino-1MQ alongside alternative small molecules and mitochondrial peptides to evaluate distinct signaling cascades. While 5-Amino-1MQ selectively targets NNMT to preserve NAD+ pools, compounds such as AICAR raw powder operate via direct enzymatic activation of 5' AMP-activated protein kinase (AMPK), bypassing the NAD+ salvage pathway entirely to stimulate fatty acid oxidation.

Similarly, the mitochondrial-derived peptide MOTS-c peptide regulates metabolic homeostasis by translocating to the nucleus during metabolic stress to promote folate cycle activation and AMPK expression. Contrastingly, 5-Amino-1MQ functions upstream of these metabolic sensors by altering methyl donor availability and cellular NAD+/NADH ratios. Assessing 5-Amino-1MQ in tandem with MOTS-c or AICAR allows investigators to dissect the cross-talk between cytosolic methylation, mitochondrial transcription, and systemic energy expenditure.

Laboratory Handling, Reconstitution, and Storage Protocol

5-Amino-1MQ is typically supplied as a lyophilized or crystalline solid salt. For optimal stability, raw powder stock should be stored at -20°C in a desiccated environment protected from direct light exposure. Under these conditions, the unconstituted compound maintains chemical stability for up to 24 months.

For reconstituting 5-Amino-1MQ in laboratory settings, sterile dimethyl sulfoxide (DMSO) or high-purity laboratory grade solvents are recommended due to the compound's hydrophobic quinolinium ring structure. Stock solutions prepared in DMSO can be aliquoted into single-use microcentrifuge tubes and stored at -80°C to minimize freeze-thaw degradation cycles.

When preparing working solutions for in vitro tissue culture assays, the DMSO stock should be diluted directly into culture media immediately prior to administration, ensuring the final organic solvent concentration remains below 0.1% v/v to avoid cellular toxicity. Reconstituted aqueous solutions should be used promptly and are not recommended for long-term storage.

Evaluating Supplier Standards: US Manufacturing & ISO 17025 Verification

Obtaining reproducible research outcomes requires sourcing compounds manufactured under standardized quality management systems. Vendors offering unverified or low-grade materials risk supplying compounds containing unreacted reagents, residual heavy metals, or structural isomers that distort biological assay data.

PX1 Research mitigates these risks by producing research chemicals in GMP-compliant facilities within the USA. Each production lot undergoes independent verification at an ISO 17025 accredited analytical testing laboratory. Standard quality control procedures include RP-HPLC for purity, ESI-MS for structural confirmation, and LAL testing for endotoxin quantitation. Every order includes a verifiable Certificate of Analysis detailing these batch parameters.

Furthermore, PX1 Research maintains efficient inventory operations with same-day shipping (Monday through Friday) originating directly from distribution facilities located in California and Arizona, preserving sample stability through minimized transit times for institutional buyers accessing our bulk research supplies.